Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data.

Yancik R, Ries LG, Yates JW.

Am J Obstet Gynecol. 1986 Mar;154(3):639-47.

PMID:
3953714
2.

Ovarian cancer. Survival and treatment differences by age.

Ries LA.

Cancer. 1993 Jan 15;71(2 Suppl):524-9.

3.
4.

Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?

Chan JK, Loizzi V, Lin YG, Osann K, Brewster WR, DiSaia PJ.

Obstet Gynecol. 2003 Jul;102(1):156-61.

PMID:
12850623
7.

The National Cancer Data Base report on ovarian cancer treatment in United States hospitals.

Partridge EE, Phillips JL, Menck HR.

Cancer. 1996 Nov 15;78(10):2236-46.

8.

Treatment and survival for women with Fallopian tube carcinoma: a population-based study.

Kosary C, Trimble EL.

Gynecol Oncol. 2002 Aug;86(2):190-1.

PMID:
12144827
9.

Poorer survival of elderly patients with ovarian cancer: a population-based study.

Petignat P, Fioretta G, Verkooijen HM, Vlastos AT, Rapiti E, Bouchardy C, Vlastos G.

Surg Oncol. 2004 Dec;13(4):181-6.

PMID:
15615654
10.

National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients.

Hightower RD, Nguyen HN, Averette HE, Hoskins W, Harrison T, Steren A.

Cancer. 1994 Jan 15;73(2):377-83.

11.

Survival among U.S. women with invasive epithelial ovarian cancer.

McGuire V, Jesser CA, Whittemore AS.

Gynecol Oncol. 2002 Mar;84(3):399-403.

PMID:
11855877
12.

Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival.

Williams MG, Bandera EV, Demissie K, Rodríguez-Rodríguez L.

Obstet Gynecol. 2009 Apr;113(4):783-9. doi: 10.1097/AOG.0b013e31819c7bdf.

PMID:
19305320
13.
14.

Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.

Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K, Chan JK.

Gynecol Oncol. 2007 Feb;104(2):396-400. Epub 2006 Oct 9.

PMID:
17030354
15.

Elderly patients with stage III or IV ovarian cancer: should they receive standard care?

Janda M, Youlden DR, Baade PD, Jackson D, Obermair A.

Int J Gynecol Cancer. 2008 Sep-Oct;18(5):896-907. Epub 2007 Nov 6.

PMID:
17986243
16.
17.

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.

Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS.

Gynecol Oncol. 2008 Jun;109(3):370-6. doi: 10.1016/j.ygyno.2008.02.006. Epub 2008 Apr 18.

PMID:
18395777
18.

Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer.

Hershman D, Jacobson JS, McBride R, Mitra N, Sundararajan V, Grann VR, Neugut AI.

Gynecol Oncol. 2004 Aug;94(2):540-9.

PMID:
15297201
19.

Long-term survival and patterns of care in women with ovarian tumors of low malignant potential.

Trimble CL, Kosary C, Trimble EL.

Gynecol Oncol. 2002 Jul;86(1):34-7.

PMID:
12079297
20.

Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.

Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, Devesa S.

Cancer. 2004 Mar 1;100(5):1045-52.

Supplemental Content

Support Center